Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases (SBIR [R43/R44])

The summary for the Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases (SBIR [R43/R44]) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Multiplex Assay Development for Arthritis and Musculoskeletal and Skin Diseases (SBIR [R43/R44])
	CFDA Number:	93.846
	CFDA Description:	Arthritis, Musculoskeletal and Skin Diseases Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-09-127
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Apr 06, 2009
	Creation Date:	Apr 06, 2009
	Original Closing Date for Applications:	Sep 07, 2012
	Current Closing Date for Applications:	Sep 07, 2012
	Archive Date:	Oct 08, 2012
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Information not provided
Grant Description: Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop and apply state-of-the-art multiplex assay technologies for measurement of multiple candidate biomarkers in small volumes of body fluid for musculoskeletal, rheumatic and skin diseases. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/pa-09-127.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (R43); • NIAMS Clinical Trial Implementation Cooperative Agreement (U01); • Support of NIAMS Program Project Grants (P01); • Multidisciplinary Clinical Research Centers (P60); • NIAMS Multi-Center Clinical Study Implementation Planning Grants (U34); • COLLABORATIVE ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES SCIENCE AWARD (CAMSSA); • NIAMS SMALL GRANT PROGRAM FOR NEW INVESTIGATORS; • SKIN DISEASES RESEARCH CORE CENTERS; • CORE CENTERS FOR MUSULOSKELETAL DISORDERS; • MICROCIRCULATION AND TARGET ORGAN DAMAGE IN RHEUMATIC AND SKIN DISEASES